Literature DB >> 8989915

Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.

Y Horio1, A Chen, P Rice, J A Roth, A M Malkinson, D S Schrump.   

Abstract

In the A/J strain of mice, urethane (ethyl carbamate) induces lung hyperplasia, adenoma, and adenocarcinoma in a time-dependent manner. These distinct morphological stages may correlate with sequential molecular genetic changes in this mouse model. To test this hypothesis, we investigated the presence of mutations involving Ki-ras and p53 in urethane-induced lung lesions in A/J mice at early and late stages of tumorigenesis. We precisely microdissected 40 lung lesions from paraffin-embedded sections. Ki-ras mutations around codon 61 and p53 mutations in exons 5-8 were identified by polymerase chain reaction-single-strand conformation polymorphism and DNA sequencing techniques. In 29 early-stage lung lesions classified as hyperplasias (seven) or adenomas (22), we observed 19 Ki-ras mutations (66%), including three silent mutations and one double mutation at different codons, and one silent p53 mutation (3.5%). In 11 late-stage adenomas, we identified nine activating Ki-ras mutations (82%) and four missense p53 mutations (36%). These results indicate that Ki-ras mutations arise early, whereas p53 mutations occur relatively late during the benign stages of urethane-induced lung carcinogenesis in A/J mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989915     DOI: 10.1002/(SICI)1098-2744(199612)17:4<217::AID-MC5>3.0.CO;2-A

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  21 in total

1.  MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation.

Authors:  K Otsubo; H Goto; M Nishio; K Kawamura; S Yanagi; W Nishie; T Sasaki; T Maehama; H Nishina; K Mimori; T Nakano; H Shimizu; T W Mak; K Nakao; Y Nakanishi; A Suzuki
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

2.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.

Authors:  Stephanie E Busch; Kay E Gurley; Russell D Moser; Christopher J Kemp
Journal:  J Pathol       Date:  2012-05-08       Impact factor: 7.996

3.  Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years.

Authors:  Christopher J Kemp
Journal:  Cold Spring Harb Protoc       Date:  2015-10-01

4.  Rare codons capacitate Kras-driven de novo tumorigenesis.

Authors:  Nicole L K Pershing; Benjamin L Lampson; Jason A Belsky; Erin Kaltenbrun; David M MacAlpine; Christopher M Counter
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

5.  Kras, Egfr, and Tp53 Mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal.

Authors:  Hue-Hua L Hong; Mark J Hoenerhoff; Thai-Vu Ton; Ronald A Herbert; Grace E Kissling; Michelle J Hooth; Mamta Behl; Kristine L Witt; Stephanie L Smith-Roe; Robert C Sills; Arun R Pandiri
Journal:  Toxicol Pathol       Date:  2015-06-09       Impact factor: 1.902

Review 6.  Vaccines based on whole recombinant Saccharomyces cerevisiae cells.

Authors:  Andressa Ardiani; Jack P Higgins; James W Hodge
Journal:  FEMS Yeast Res       Date:  2010-12       Impact factor: 2.796

7.  Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

Authors:  Ayumu Taguchi; Katerina Politi; Sharon J Pitteri; William W Lockwood; Vitor M Faça; Karen Kelly-Spratt; Chee-Hong Wong; Qing Zhang; Alice Chin; Kwon-Sik Park; Gary Goodman; Adi F Gazdar; Julien Sage; Daniela M Dinulescu; Raju Kucherlapati; Ronald A Depinho; Christopher J Kemp; Harold E Varmus; Samir M Hanash
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

8.  Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors.

Authors:  Stephanie T Dance-Barnes; Nancy D Kock; Heather S Floyd; Joseph E Moore; Libyadda J Mosley; Ralph B D'Agostino; Mark J Pettenati; Mark Steven Miller
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-27       Impact factor: 4.219

9.  A mouse model repository for cancer biomarker discovery.

Authors:  Karen S Kelly-Spratt; A Erik Kasarda; Mark Igra; Christopher J Kemp
Journal:  J Proteome Res       Date:  2008-07-15       Impact factor: 4.466

Review 10.  The Kras2 oncogene and mouse lung carcinogenesis.

Authors:  Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.